Update in Endocrinology
Authors: Janet A. Schlechte
Journal: Annals of Internal Medicine (2005)

Updates18 January 2005Update in EndocrinologyJanet A. Schlechte, MDJanet A. Schlechte, MDFrom the University of Iowa, Iowa City, Iowa.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-142-2-200501180-00012 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail This year's Update in Endocrinology incorporates articles on diabetes, thyroid disorders, osteoporosis, adrenal incidentalomas, and women's health.DiabetesIntensive Treatment of Type 1 Diabetes Had a Sustained EffectSustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA. 2003;290:2159-67. [PMID: 14570951]In the Diabetes Control and Complications Trial (DCCT) (1), individuals with no clinically evident complications of type 1 diabetes or early microvascular complications were exposed to different levels of glycemic control for an average of 6.5 years. At the end of the trial, those ...References1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977-86. [PMID: 8366922] CrossrefMedlineGoogle Scholar2. Schwartz S, Sievers R, Strange P, Lyness WH, Hollander P. Insulin 70/30 mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugs: efficacy, safety, and cost analysis. Diabetes Care. 2003;26:2238-43. [PMID: 12882842] CrossrefMedlineGoogle Scholar3. Clyde PW, Harari AE, Getka EJ, Shakir KM. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized, controlled trial. JAMA. 2003;290:2952-8. [PMID: 14665656] CrossrefMedlineGoogle Scholar4. Sawka AM, Gerstein HC, Marriott MJ, MacQueen GM, Joffe RT. Does a combination regimen of thyroxine (T4) and 3,5,3′-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab. 2003;88:4551-5. [PMID: 14557420] CrossrefMedlineGoogle Scholar5. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, et al. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol. 2002;20:1578-83. [PMID: 11896107] CrossrefMedlineGoogle Scholar6. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, LaVasseur BI, Barton DL, et al. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet. 2000;356:2059-63. [PMID: 11145492] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From the University of Iowa, Iowa City, Iowa.Disclosures: None disclosed.Corresponding Author: Janet A. Schlechte, MD, Department of Internal Medicine, University of Iowa Hospitals and Clinics, 200 Hawkins Drive, Iowa City, IA 52242; e-mail, [email protected]edu. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 18 January 2005Volume 142, Issue 2Page: 126-131KeywordsBone mineral densityHemoglobinHypothyroidismInsulinOsteoporosisPancreasParathyroid hormoneRenal transplantationTransplantationTriiodothyronine ePublished: 18 January 2005 Issue Published: 18 January 2005 Copyright & PermissionsCopyright © 2005 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...